Detalhe da pesquisa
1.
A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Patients With Esophageal Adenocarcinoma.
Ann Surg
; 278(5): e1003-e1010, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185875
2.
The role of surgeons during the COVID-19 pandemic: impact on training and lessons learned from a surgical resident's perspective.
Surg Endosc
; 35(7): 3430-3436, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32666253
3.
Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation.
Artif Organs
; 39(7): 569-75, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25810063
4.
Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma.
J Immunother Cancer
; 11(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349126
5.
Micropapillary and Solid Histologic Patterns in N1 and N2 Lymph Node Metastases Are Independent Factors of Poor Prognosis in Patients With Stages II to III Lung Adenocarcinoma.
J Thorac Oncol
; 18(5): 608-619, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681298
6.
CAR T-cell therapy for pleural mesothelioma: Rationale, preclinical development, and clinical trials.
Lung Cancer
; 157: 48-59, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972125
7.
Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
Circ Heart Fail
; 11(9): e004638, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30354363
8.
Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis.
Ann Thorac Surg
; 105(3): 807-814, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28942075
9.
Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.
J Thorac Cardiovasc Surg
; 151(6): 1747-1754.e1, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26971377
10.
Anatomic Mesenchymal Stem Cell-Based Engineered Cartilage Constructs for Biologic Total Joint Replacement.
Tissue Eng Part A
; 22(3-4): 386-95, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26871863
11.
Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
J Thorac Cardiovasc Surg
; 149(1): 281-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25439775
12.
Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
JACC Heart Fail
; 3(11): 860-9, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26454844
13.
Augmentation of integrin-mediated mechanotransduction by hyaluronic acid.
Biomaterials
; 35(1): 71-82, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24120037